Drugs - Drugs Xagena

Drugs

Home Page

Xagena Medicine

Xagena.net

Inoperable hepatocellular carcinoma: FDA has approved Nexavar

Avandia: FDA has added boxed warning for cardiovascular risks

Treatment of pain associated with osteoarthritis: Voltaren gel

Antibiotics: Cefepime associated with increased mortality

Hypertension: FDA has approved Bystolic, a beta-blocker

Valproate therapy: risk factors for development of subclinical hypothyroidism

Refractory partial epilepsy: no advantage for Zonisamide

Tumors: recommendations on the use of Zometa

Antioxidants show no clear benefit against cardiovascular events, death in high-risk women

Bizarre sleep related effects linked to Zolpidem

Safety information on Rosiglitazone, a diabetes drug

Diabetes: Avandia linked to risk of myocardial infarction and heart-related deaths

FDA: Neupro patch for treatment of early Parkinson's disease approved

Antidepressant medications: new warnings about suicidal thinking, behavior in young adults

Baraclude: occurrence of a resistant HIV variant in a patient co-infected with HIV and HBV

EMEA has granted Enzastaurin orphan drug status for treatment of diffuse large B-cell lymphoma

Pergolide, a drug for Parkinson's disease, withdrawn for serious damage to heart valves

FDA: label change for all sleep disorder drug products requested

FDA: Tykerb for advanced breast cancer patients approved

TNF-alpha inhibitors are associated with several serious reactions

Drug-induced pancreatitis

Leflunomide associated with interstitial lung disease

FDA approves Tekturna, the first renin inhibitor for treating hypertension

FDA has approved Humira for Crohn's disease

Increased incidence of grade IIIA acute rejection in heart transplant patients switched from calcineurin inhibitor and CellCept to Rapamune and CellCept at 12 weeks post heart transplantation

ADHD drugs linked to cardiovascular and psychiatric adverse events

Levofloxacin may cause dysglycemia and liver disorders

Alphanate in the treatment of von Willebrand disease

FDA has restricted use of antibiotic Ketek

European Union: Mircera for treatment of anemia related to chronic kidney disease approved

Next Pages 1 2 3 [4] 5 6 7 8 9 10

Link

• Allergology

• Biomedicine

• Dermatology

• Diabetology

• Diagnostics

• Drugs

• Endocrinology

• Gastroenterology

• Gene Medicine

• Infectivology

• Ophthalmology

• Pharmacology

• Rheumatology

• Stem Therapy

n Xagena.it

Powered by Luca Malattia - LM Web Solutions